Citius Pharmaceuticals, Inc. → Citius Oncology, Inc. CTOR

Stake: — Shares: 66,049,615 Class: Common Shares, $0.0001 par value per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 18/100

Active Schedule 13D filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 2.68

227,455 shares short · -21.5% vs prior

Post-Filing Returns · since 2026-05-15 on CTOR

+1 day

-13.9%

+5 days

-14.2%

+30 days

-29.4%

+60 days

-32.5%

+90 days

—

+180 days

—

Anchor price 0.96 on closest trading day on/after 2026-05-15. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →